(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) jumped by a staggering 17.06% in 7 days from $6.33 to $7.41 at 11:11 EST on Sunday, after three sequential sessions in a row of gains. NASDAQ Composite is jumping 1% to $15,860.96, after two consecutive sessions in a row of gains.
Catalyst Pharmaceuticals’s last close was $7.41, 1.23% higher than its 52-week high of $7.32.
Volume
Today’s last reported volume for Catalyst Pharmaceuticals is 2085013 which is 138.21% above its average volume of 875260.
Catalyst Pharmaceuticals’s Sales
Catalyst Pharmaceuticals’s sales growth is 18% for the present quarter and 15.6% for the next.
Catalyst Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.
Volatility
Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was 0.71%, 0.14%, and 2.28%, respectively.
Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.32% (last week), 1.82% (last month), and 2.28% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).
Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals’s stock is valued at $7.41 at 11:11 EST, higher than its 52-week high of $7.32.
Catalyst Pharmaceuticals’s Moving Average
Catalyst Pharmaceuticals’s value is way higher than its 50-day moving average of $5.85 and way above its 200-day moving average of $5.56.
More news about Catalyst Pharmaceuticals (CPRX).
